A Study of Keluo Xin Capsule Compare to Placebo in Terms of Efficacy and Safety in Patients With Diabetic Retinopathy
Clinical trial NCT03258242 · UNKNOWN
Trial details
- NCT number
- NCT03258242
- Sponsor
- Chengdu Kanghong Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-31
- Primary completion
- 2019-08-31
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.